Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and ...

Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown positive Phase 3 results in treating type 2 ...

One of the foremost hurdles encountered in the pursuit of weight loss is the apprehension of physical exhaustion and the ...

In the same way Ozempic has obliterated the body positivity movement, new “undetectable” cosmetic interventions are creating ...

Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top ...

Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...